Common Contracts

FOURTH SUPPLEMENTAL DEBENTURE INDENTURE

Fourth Supplemental Debenture Indenture • February 13th, 2019 • Ontario

• Contract Type
  Fourth Supplemental Debenture Indenture
• Filed
  February 13th, 2019
• Jurisdiction
  Ontario

WHEREAS the Company, MPX Bioceutical Corporation (“MPX Corp”) (amalgamation predecessor to the Parent) and the Trustee entered into an indenture dated May 25, 2018 (the “Base Indenture”), providing for the issuance of convertible debentures (the “Debentures”) in the aggregate principal amount of US$49,257,572.60;